Hi folks
Sad how drugs like Tamiflu can get the go ahead . Nothing to do with Involvement of certain political figures - it makes me sick . The key issue for Bota is stockpiling . If stockpiling is reduced , this impacts Bota revenue as this is one the two key future revenue streams , the one they are hoping to make the greatest margins on .
Bota need to have another growth path to reduce the risks associated with the current model which is all about Lani approval and revenue
Add to My Watchlist
What is My Watchlist?